Generic Pharmaceuticals Company Investment Opportunity in Indore, India

- API manufacturing company based in Indore, India. For the past 3 decades, this company has focused on API development, manufacturing, and marketing of APIs and intermediates. It has a state-of-the-art manufacturing facility and is a state GMP-certified plant facility.

- This is a research-driven organization – that develops technology, translates it to production, and then delivers it to customers. With a strong commitment to excellence in product quality (which is never compromised) and adherence to strict delivery schedules, they are presently exporting to 14 countries around the world.

- The company’s strength lies in providing extended support to its customers. Their success has been validated by what they hold the dearest – product excellence and customer service. The company believes that long-term business is rooted in values and business ethics.

- It is one of the leading manufacturers of Tinidazole and Ornidazole, which are considered anti-protozoal molecules, a segment of bulk drugs. Sales have shown an increasing trend.

- The company has received Good Manufacturing Practices (GMP) Certificate from the Office of the Controller of Food and Drugs Administration, Madhya Pradesh.

Note: this transaction is being handled by an advisory firm based in Rajkot.

Allopurinol.

Alprazolam.

Disulfiram.

Etamsylate.

Mefenamic Acid.

Ornidazole.

Nitazoxanide.

Propranolol HCL.

Tinidazole.

Guaifenesin.

Baclofen.

7Chloro1, 3dihydro5phenyl 2h, 1,4ben zodiaze 2Thione.

3,4 chlorophenyl Glutamic acid.

10,888 sq. ft. - building area.

27,750 sq. ft. - land area.

300 MT of installed capacity.

12 reactors.

CGMP certified.

Owned facility with a building area of 10,888 sq. ft. constructed on 27,750 sq. ft. of land area.

The facility is CGMP certified.

This is an unlisted public company with multiple shareholders.